Figure 5From: Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparationsSynchronous fluorescence spectra of EBS at 457 nm in presence of: a) Alkaline degradation product. b) Acidic degradation product. c) UV degradation product.Back to article page